The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC.
 
Julien Mazières
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Research Funding - Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Oliver Molinier
Consulting or Advisory Role - Boehringer Ingelheim; Roche Pharma AG
 
Isabelle Monnet
No Relationships to Disclose
 
Clarisse Audigier-Valette
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche; Sysmex
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Roche; Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
 
Benjamin Besse
No Relationships to Disclose
 
Anne Claire Toffart
Consulting or Advisory Role - Boehringer Ingelheim; Roche Pharma AG
 
Patrick-Aldo Renault
No Relationships to Disclose
 
Philippe Masson
Honoraria - Novartis; Teva
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Bertrand Mennecier
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Pierre Fabre; Vifor Pharma
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MSD (Inst); novartis (Inst)
Expert Testimony - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer
 
Severine Moreau Fraboulet
No Relationships to Disclose
 
Sandrine Hiret
No Relationships to Disclose
 
Virginie Westeel
No Relationships to Disclose
 
Patrick Dumont
No Relationships to Disclose
 
Alexis B. Cortot
Honoraria - AstraZeneca; Boehringer Ingelheim
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline; Lilly
 
Eric Pichon
Speakers' Bureau - Chugai Pharma
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Marie Paule Lebitasy
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Gerard Zalcman
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche